Contact
Please use this form to send email to PR contact of this press release:
CHMP issues positive opinion for Libtayo® (cemiplimab) in advanced cutaneous squamous cell carcinoma
TO:
Please use this form to send email to PR contact of this press release:
CHMP issues positive opinion for Libtayo® (cemiplimab) in advanced cutaneous squamous cell carcinoma
TO: